M

MNOV

Medicinova

1.66

0.47+39.50%
After Hours: 1.510  -0.15  -9.04%19:59 10/31 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE1.360/1.190
TODAY RANGE1.200-1.960
VOL47.60M
MARKET CAP81.42M
52 WEEK RANGE1.130-2.550
AVG VOL (3M)873.40K
% TURNOVER97.04%
TURNOVER--
P/E (TTM)-6.8908
% RANGE63.87%
EPS(TTM)-0.2409
P/E(FORWARD)-3.3200
P/B1.737
BVPS0.9554
DIVIDEND--
P/S81.37
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP78.99M
SHARES OUTSTANDING49.05M
NEXT EARNINGS11/11-11/17
FREE FLOAT47.58M
LOT SIZE1
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

M

Medicinova

MNOV

+39.50%
1.66

R

Regeneron Pharmaceuticals

REGN

-0.34%
651.80

E

Entero Therapeutics

ENTO

-4.06%
4.25

B

BIONTECH

BNTX

-0.73%
103.91

U

United Therapeutics Corp.

UTHR

-1.79%
445.43

S

Siga Technologie

SIGA

-0.36%
8.28

V

Vertex Pharmaceuticals Inc

VRTX

+1.35%
425.57

M

Moderna

MRNA

-3.48%
27.16

C

Charles Riv Labs Intl Inc

CRL

+0.54%
180.07

M

Medpace Holdings

MEDP

+0.78%
584.91

T

Talphera Inc

TLPH

+8.06%
1.34

I

ICON PLC

ICLR

+3.93%
171.82

C

China Biologic

CBPO

--
119.99

I

Iqvia Hldgs Inc

IQV

0.00%
216.46

M

MOLECULAR PARTNERS AG

MOLN

-3.62%
3.63

P

PRA Health

PRAH

--
165.21

A

Arcturus Therape

ARCT

+3.53%
9.97

G

Gilead Sciences Inc

GILD

+1.14%
119.79

I

Incyte Corp

INCY

+0.96%
93.48

A

Aptevo Therapeutics Inc

APVO

+10.71%
1.55

B

Biospecifics

BSTC

+0.15%
88.53
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.